{
    "Trade/Device Name(s)": [
        "CAPI 3 Hb A1c",
        "MULTI-SYSTEM Hb A1c CAPILLARY Controls (2)"
    ],
    "Submitter Information": "Sebia, Inc.",
    "510(k) Number": "K162281",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122101",
        "K133344"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JJX"
    ],
    "Summary Letter Date": "August 8, 2016",
    "Summary Letter Received Date": "August 15, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7470",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Hemoglobin A2",
        "Hemoglobin F",
        "Hemoglobin S",
        "Hemoglobin C",
        "Hemoglobin D",
        "Hemoglobin E",
        "Labile HbA1c",
        "Carbamylated hemoglobin",
        "Acetylated hemoglobin"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "Test tube",
        "Closed conical tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SEBIA CAPILLARYS 3 TERA",
        "SEBIA CAPILLARYS 2 FLEX-PIERCING",
        "SEBIA MINICAP FLEX-PIERCING"
    ],
    "Method(s)/Technology(ies)": [
        "Capillary electrophoresis"
    ],
    "Methodologies": [
        "Electrophoretic separation",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Kit",
        "Control",
        "Instrument",
        "Reagent",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for CAPI 3 Hb A1c kit and MULTI-SYSTEM Hb A1c CAPILLARY Controls using capillary electrophoresis for quantifying hemoglobin A1c in venous whole blood",
    "Indications for Use Summary": "CAPI 3 Hb A1c kit is intended for separation and quantification of HbA1c in venous whole blood to monitor long-term glycemic control in diabetes; not for screening or diagnosis; controls are for migration and quality control of HbA1c quantification with SEBIA capillary electrophoresis systems.",
    "fda_folder": "Hematology"
}